CRT-800.42 Transcatheter Atrial Septal Defect Occluder Devices: Trends in Adverse Events and Erosions in a Public Database

The risk of cardiac erosion with commercially available atrial septal defect occluders has led to changes in device labeling and implantation technique. Previous reports have described publicly-available data on erosion events but have not included recent experience. The FDA Manufacturer and User